馮 皓,陳瑞兵,張 磊(第二軍醫(yī)大學(xué)藥學(xué)院藥用植物學(xué)教研室,上海 200433)
·論著·
蠐螬脂溶性成分的研究
馮 皓,陳瑞兵,張 磊(第二軍醫(yī)大學(xué)藥學(xué)院藥用植物學(xué)教研室,上海 200433)
目的研究蠐螬提取物中的脂溶性成分。方法采用乙酸乙酯回流提取蠐螬中的脂溶性成分,對(duì)其進(jìn)行氣相色譜-質(zhì)譜法(GC-MS)分析,并對(duì)主要脂溶性成分進(jìn)行定性分析。結(jié)果從蠐螬脂溶性成分中鑒定出33個(gè)化合物,十五酸、Z-11-十六烯酸、十六酸、十七酸、十八烯酸和十八酸為其主要的脂溶性成分。結(jié)論本研究為進(jìn)一步研究動(dòng)物藥和確認(rèn)蠐螬的有效成分奠定了基礎(chǔ)。
蠐螬;鰓金龜;乙酸乙酯;氣相色譜-質(zhì)譜
In China,the subfamily Melolonthidae is represented in the literature about 500species[1].Among them,four species larvae of Holotrichia diomphalia Bates,Holotrichia oblila Fald,Holotrichia sauteri Moser and Holotrichia parallela Motschulsky are traditionally used in China to treat arthrolithiasis,tetanus,erysipelas and superficial infection[2-4].
The chemical composition of themedicinal animal has few been studied in detail.We reported previously the composition on the petroleum ether extract of H.diomphalia using GC-MS[5],however,liposoluble constituent extracted from H.diomphalia has not been studied.Through the investigation of H.diomphalia,we discovered that the ethylacetate extract of H.diomphalia contained a host of liposoluble constituent.Thus,the extract was identified by GC-MS and we firstly reported the result on GC-MS determination of liposoluble constituentofethylacetate extractof H.diomphalia.
2.1 Materials Medicalmaterials of H.diomphalia were purchased from local market and identified by Professor Zhang Hanming,Second M ilitary Medical University,Shanghai,China.All standard compounds were purchased from Sigma(St.Louis,MO,USA).Ultrapure water was produced by a Milli-Q Reagent Water System(M illipore,MA,USA).All experimentswere carried out on a Thermo Focus DSQ gas chromatograph and interfaced to a Thermo Focus DSQ mass selective detector.
2.2 Ext ractmethods Dried(50℃)and chopped H.diomphalia powder was refluxed three times(3heach time)with 75%ethanol.After filtration,the clear supernatant was then concentrated at 60℃.Concentrated ethanol extract was partitioned between water and petroleum ether(60-90℃).After removing petroleum ether fraction,the aqueous layer was partitioned again with acetic ether.The extract of acetic ether was evaporated and the residue was used for the following experiment.
2.3 GC-MS condition GC-MS analysis was carried out on a Thermo Focus DSQ gas chromatograph fitted w ith a fused silica HP-5MS capillary column(30m× 0.25mm×0.25μm).The oven temperaturewas programmed from 50–300°C at15°C/min.Helium was used asa carrier gasata flow rate of 1.0m l/min.The gas chromatograph was coupled to a Thermo Focus DSQ mass selective detector.The MS operating parameters were:ionization voltage,70eV;ion source temperature,250℃.Identification of components of the petroleum ether extract was based on retention times(Rt)of relative fat acid and computermatching with the NIST98.Library,as well as comparison of the fragmentation patterns of the mass spectra w ith those reported in the literatures[6,7].
In total,as shown in the Table 1,33compounds were identified in ethylacetate extract of H.diomphalia through GC-MS.Pentadecylic acid,Z-11-Hexadecenoic acid,hexadecanoic acid,heptadecanoic acid,oleic acid and octadecanoic acid weremain components of the ethylacetate extract.The retention time(Rt)and relative percentage content(%)of compoundswere listed in Table 1.
In China,H.diomphalia,asa traditionalmedicinal animal,has been used to treat arthrolithiasis and infection,but the chemical composition and active compounds has notbeen identified and studied.Here,based on the previous research of the composition on the petroleum ether extract of H.diomphalia,this time we focused on the liposoluble constituent using GC-MSand 33compoundswere identified.Thiswork will contribute to the study of active compounds in H.diomphalia andmedicinalanimals.
Table 1 Composition of the ethylacetate extractof H.diomphalia
[1] Tang ZT.Taxonomy of insects[M].Beijing:China Forestry Publishing House,1989:128.
[2] Jiang SJ.Integration onmedical insects in China[M].Beijing:China Forestry Publishing House,1999:185.
[3] Jiangsu New Medical College.Dictionary of Chinese herbal medicines[M].Shanghai:Shanghai Science and Technology Publisher,1986:212.
[4] National Pharmacopoeia Committee.Pharmacopoeia of Peoples Republic of China,Part 1[S].Beijing:Chemical Industry Press,2010:167.
[5] Dong QF,Wang JL,Zhang L,et al.Antifungal activity of crude extracts and fat-soluble constituentsof Holotrichia diomphalia larvae[J].Bioresour Technol,2008,99(17):8521-8523.
[6] Adams RP.Identification of essential oil components by gas chromatography/mass spectroscopy Robert P.Adams[J].JAm SocMass Spectrom,1997,8(6):671-672.
[7] Swigar AA,Silverstein RM,Monoterpenes.Monoterpenes infrared,mass,1H-NMR,13C-NMR spectra and kovats indices[M].Milwaukee:Aldrich Chemical Company Inc.,1981:299-300.
【參考文獻(xiàn)】
[1] 李承珠,嘉 寶,楊詩(shī)春,等.丹參素對(duì)血小板釋放血管收縮物質(zhì)的影響[J].中西醫(yī)結(jié)合雜志,1984,4(9):532-565.
[2] 顧揚(yáng)洪,張彩英,黃桂秋,等.丹參和丹參素對(duì)牛內(nèi)皮細(xì)胞抗凝和纖溶功能的影響[J].第二軍醫(yī)大學(xué)學(xué)報(bào),1990,10(3):208-212.
[3] 孫錫銘,蔡海江,宋素云,等.丹參素的新藥理作用[J].中草藥,1991,21(1):20-23.
[4] 王 南,蔡海江,朱 宇,等.丹參素對(duì)牛主動(dòng)脈平滑肌細(xì)胞氧化修飾LDL的抑制作用[J].南京醫(yī)科大學(xué)學(xué)報(bào),1994,14(4):529-531.
[5] 蔣 莉,李躍華,戚曉紅,等.丹參素對(duì)內(nèi)毒素性肝損傷的防護(hù)作用及其機(jī)制[J].中西醫(yī)結(jié)合肝病雜志,1999,9(2):30-32.
[6] 鄭元義,戴立里,王文兵,等.丹參素治療肝纖維化及其作用機(jī)制研究[J].中華肝臟病雜志,2003,11(5):288-290.
[7] 王文俊,吳咸中,姚 智,等.大黃索、丹參素對(duì)單核細(xì)胞分泌炎性細(xì)胞因子的調(diào)節(jié)[J].中國(guó)免疫學(xué)雜志,1995,11(6):370-372.
[8] Lam FFY,Yeung JHK,Chan KM,et al.Relaxant effects of danshen aqueous ex tract and its constituent Danshensu on rat coronary artery aremediated by inhibition of calcium channels[J].Vascul Pharmacol,2007,46(4):271-277.
[9] Zhao GR,Zhang HM,Ye TX,et al.Characterization of the radical scavenging and antioxidant activities of Danshensu and salvianolic acid B[J].Food Chem Toxicol,2008,46(1):73-81.
[10] 眭 建,林 楓.丹參素對(duì)胃腺癌NGCC細(xì)胞株的作用[J].鎮(zhèn)江醫(yī)學(xué)院學(xué)報(bào),1997,7(4):384-285.
[11] 方 杰.丹參素對(duì)乳腺癌MCF細(xì)胞株的作用[J].中國(guó)老年學(xué)雜志,2003,3(23):168-169.
[12] 方 芳,王平珍,邱 蕓.中藥丹參的臨床研究進(jìn)展[J].內(nèi)蒙古中醫(yī)藥,2012,19:81-82.
[13] 權(quán) 偉,周 丹,郭 超,等.丹參素鈉通過(guò)抑制炎癥反應(yīng)對(duì)心肌缺血-再灌注損傷的保護(hù)作用[J].中南藥學(xué),2012,10(12):885-888.
[14] 程彰華,樓亞平,戴華娟,等.丹參素對(duì)微循環(huán)障礙和血漿乳酸含量影響的實(shí)驗(yàn)研究[J].上海醫(yī)科大學(xué)學(xué)報(bào),1987,14(1):25-29.
[15] 王定遠(yuǎn).新型丹參素衍生物的合成及初步活性研究[D].廣州:廣州大學(xué),2011.
[16] Dong CN,WangY,Zhu YZ.Asymmetric synthesis and biological evaluation of Danshensu derivatives as anti-myocardial ischem ia drug candidates[J].Bioorg Med Chem,2009,17:3499-3507.
[17] 張智波,董紀(jì)昌,金昔陸,等.八種丹參素衍生物的合成[J].上海醫(yī)科大學(xué)學(xué)報(bào),1996,23(增刊):26-28.
[18] 崔慶彬,單璐琛,朱 華,等.丹參素結(jié)構(gòu)中醇羥基的修飾與初步活性評(píng)價(jià)[J].國(guó)際藥學(xué)研究雜志,2013,40(6):795-800.
[19] 鄭曉輝,張群正,王世祥,等.β-(3,4-二羥基苯基)-α-羥基丙酸異丙酯、其合成方法和用途:中國(guó),CN200610042787.3[P].2006-05-15.
[20] 向 卓,景臨林,劉文中,等.乙酰丹參素單硝酸異山梨醇酯的合成及對(duì)心肌缺血/再灌注大鼠心肌的保護(hù)作用[J].第四軍醫(yī)大學(xué)學(xué)報(bào),2009,30(14):1257-1261.
[21] Wang TF,Shu JJ.Synthesis and biological activities of novel Danshensu am ide derivatives as anti-myocardial ischem ia agents[J].Lat Am JPharm,2011,30(7),1355-1359.
[22] 朱依諄,王 洋,董村南,等.一種丹參素衍生物及其制備方法和在藥學(xué)上的應(yīng)用:中國(guó),CN 200810039162.0[P].2008-06-18.
[收稿日期]2015-01-23[修回日期]2015-04-02[本文編輯]顧文華
Liposoluble constituent of ethylacetate extract of Holotrichia diomphalia larvae
FENG Hao,CHEN Ruibing,ZHANG Lei(Departmentof Pharmaceutical Botany,Schoolof Pharmacy,Second M ilitary Medical University,Shanghai200433,China)
ObjectiveTo analyze the chemical components of the liposoluble constituent of Holotrichia diomphalia larvae.MethodsEssential liposoluble compoundswere extracted from H.diomphalia through ethylacetate.GC-MSanalysiswas used to identify itsmain components.Results33peakswere separated and 33compoundswere identified from ethylacetate-extracted H.diomphalia.The main compounds were pentadecylic acid,Z-11-Hexadecenoic acid,hexadecanoic acid,heptadecanoic acid,oleic acid and octadecanoic acid.ConclusionThiswork w ill contribute to the study ofmedicinal animals and confirmation of active compounds in H.diom phalia.
Holotrichia diom phalia;Melolonthidae;ethylacetate;GC-MS
R931.74
A
1006-0111(2015)06-0533-03
10.3969/j.issn.1006-0111.2015.06.014
2015-01-29
2015-09-15[本文編輯]李睿旻
馮 皓,博士.研究方向:新藥研發(fā).E-mail:fenghao@sphchina.com
張 磊,碩士生導(dǎo)師.研究方向:藥用植物次生代謝工程.Tel:(021)81871307;E-mail:leizhang100@163.com